¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"substance dependence disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® narcissistic personality disorder ÇÑ±Û ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö
¼³¸í   
  ÀÚ½ÅÀÇ Á߿伺°ú µ¶Æ¯ÇÔ, À¯ÀÏÇÔ¿¡ ´ëÇÑ ±¤ÀûÀΠÁýÂø°ú ÀÚ½ÅÀÌ ¼º°øÇÒ °ÍÀ̶ó´Â Áö³ªÄ£ ÁýÂøÀ» º¸¿©Áִ ¼º°ÝÀå¾Ö. Áö³ªÄ£ Àڱ⿡ÀÇ ¸¸Á·°¨À» °¡Áö°í, Áö³ªÄ£ Àڽۨ, ¼º°ø¿¡ ´ëÇÑ È®½ÅÀ» Áö´Ï°í ÀÖ´Ù.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
¿µ¹® affective disorder ÇÑ±Û Á¤µ¿Àå¾Ö
¼³¸í   
  ÁַΠ±âºÐÀÇ Àå¾Ö°¡ ÁÖÃàÀÌ µÇ´Â ÀÏ·ÃÀÇ Á¤½ÅÀå¾ÖÀÌ´Ù. ÀÌ º´ÀÇ ¹üÁÖ¿¡´Â(¿ì¿ïº´£­Áö¼ÓÀûÀ¸·Î ¿ì¿ïÇÑ ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ ³ªÅ¸³ª´Â º´), (Á¶º´£­Áö¼ÓÀûÀ¸·Î µé¶á ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ °è¼ÓµÇ´Â º´) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® psychiatric disorder(s) ÇÑ±Û Á¤½ÅÁúȯ
¼³¸í   
  Á¤½Å»óÅ¿¡ ÀÌ»óÀÌ Àִ ÁúȯÀ¸·Î, Á¤½ÅºÐ¿­º´, Á¤µ¿Àå¾Ö, ÀΰÝÀå¾Ö µîÀÌ ÀÖ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • periaqueductal gray substance
    ¼öµµ°üÁÖÀ§È¸»öÁú, ¼ö°üÁÖÀ§È¸»öÁú
  • reducing substance
    ȯ¿ø¹°Áú
  • reticular substance
    ±×¹°±¸¼º¹°Áú, ¸Á»óü
  • radioactive substance
    ¹æ»ç¼º¹°Áú
  • specific soluble substance
    ƯÀ̰¡¿ë¹°Áú
  • spongy substance
    °¹¼ØÁú, ÇØ¸éÁú
  • substance
    ¹°Áú
  • substance P
    ¼­ºê½ºÅĽºP, ¹°ÁúP
  • substance withdrawal
    ¹°Áú±Ý´Ü
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • visual substance
    ½Ã°¢¹°Áú
  • volatile substance
    Èֹ߹°Áú
  • white substance
    ¹é(»ö)Áú
  • zymoplastic substance
    ÀÀÇ÷ÃËÁø¹°Áú
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • language disorder
    ¾ð¾îÀå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
  • metabolic disorder
    ´ë»çÀå¾Ö
  • neuromuscular disorder
    ½Å°æ±ÙÀ°Àå¾Ö, ½Å°æ±ÙÀ°Áúȯ
  • obsessive-compulsive disorder
    °­¹ÚÀå¾Ö, °­¹Úº´
  • oppositional defiant disorder
    Àû´ëÀû¹ÝÇ×Àå¾Ö
  • panic disorder
    °øÈ²Àå¾Ö, °øÈ²º´
  • paranoid disorder
    (¢¡delusional disorder) ÆíÁýÀå¾Ö, ÆíÁýº´
  • personality disorder
    ÀΰÝÀå¾Ö, ¼º°ÝÀå¾Ö
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • premenstrual dysphoric disorder
    ¿ù°æÀüºÒÄèÀå¾Ö, ¿ù°æÀüºÒÄ躴
  • psychogenic disorder
    Á¤½ÅÅ¿Àå¾Ö, ½ÉÀμºÀå¾Ö
  • reading disorder
    ÀбâÀå¾Ö
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte sensitizing substance
    ÀûÇ÷±¸¹Î°¨¹°Áú
  • exophthalmos-producing substance
    ´«µ¹ÃâÀ¯¹ß¹°Áú
  • ferromagnetic substance
    ¼¾ÀÚ¼º¹°Áú, °­ÀÚ¼ºÃ¼
  • fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
  • fundamental substance
    ¹«ÇüÁú
  • gap substance
    »çÀ̹°Áú
  • gelatinous substance
    ¾Æ±³Áú
  • goitrogenic substance
    ¹æÆÐ»ùÁ¾À¯¹ß¹°Áú, °©»ó»ùÁ¾À¯¹ß¹°Áú
  • gray substance
    ȸ»öÁú
  • ground substance
    ¹ÙÅÁÁú
  • heparinoid substance
    ÇìÆÄ¸°¼º¹°Áú
  • heterogeneous substance
    ºÒ±ÕÁúü
  • horny substance
    °¢Áú
  • inducer substance
    À¯µµ¹°Áú
  • inhibitor substance
    ¾ïÁ¦¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • antithyroid substance
    Ç×°©»ó¼±¹°Áú.
  • antiyeast substance
    Ç×È¿¸ð¹°Áú.
  • gelatinous substance
    ¾ÆaÁú, a¾çÁú(ÎïåÆòõ).
  • gelatinous substance
    ¾Æ±³Áú
  • gray substance
    ȸ»öÁú.
  • ground substance
    ±âÀú¹°Áú(Ðñî¼Úªòõ), ±âÁú(Ðñòõ).
  • heparinoid substance
    ÇìÆÄ¸°¾ç¹°Áú.
  • heterogeneous substance
    ºÒ±ÕÁúü.
  • horny substance
    °¢Áú(ÊÇòõ).
  • pneumococcal C-substance
    Æó·Å±¸±Õ C-¹°Áú
  • postacrosomal substance
    ÷´ÜüµÚ¹°Áú
  • posterior perforated substance
    µÚ°üÅëÁú
  • posterior perforated substance ³ª substantia perforata posterior
    ÈÄÀ¯°øÁú(ý­êóÍîòõ).
  • posterior perforated substance ³ª substantia perforata posterior
    ÈÄÀ¯°øÁú(ý­êóÍîòõ).
  • pressor substance
    Ç÷¾Ð»ó½Â¹°Áú(¡­Úªòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • antibacterial substance
    Ç×±Õ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú.
  • antimold (substance)
    Ç×°õÆÎÀÌ(¹°Áú).
  • antithyroid substance
    Ç×°©»ó¼±¹°Áú.
  • antiyeast substance
    Ç×È¿¸ð¹°Áú.
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú.
  • blood substance
    Ç÷¾× ´ë¿ëÁ¦(úìäûÓÛéÄð¥)
  • bone substance
    °ñ Áú(Íéòõ).
  • carcinogen =carcinogenic substance
    ¹ß¾Ï(¼º)¹°Áú(Û¡ç÷àõÚªòõ).[¾à¸®] ¹ß¾Ï¹°Áú<¿ø>, ¹ß¾Ï¼º(Û¡äßàõ).
  • carcinogen =carcinogenic substance
    ¹ß¾Ï(¼º)¹°Áú(ËÑËçËÛËÑ̤).¾à¸® ¹ß¾Ï¹°Áú<¿ø>, ¹ß¾Ï¼º(ËÑËâËÛ).
  • cement substance
    Á¢ÇÕÁú(ïÈùêòõ).
  • central gelatinous substance
    Á߽ɾƱ³Áú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Osteoid substance
    Dz»À¹°Áú
    [¿¾ ¿ë¾î] °ñ¾çÁú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ADDU alcohol and drug dependence unit
AL absolute latency; acinar lumen; acute leukemia; adaptation level; albumin; alcoholism [and other dru...
PDC parkinsonism dementia complex; pediatric cardiology; penta-decylcatechol; phosducin; physical depend...
PPD packs per day; paraphenylenediamine; percussion and postural drainage; permanent partial disability;...
SADD Short-Alcohol Dependence Data [questionnaire]; standardized assessment of depressive disorders; Stud...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DLS Digitalis-like substance
DLIS Digoxin-like immunoreactive substance
EDLS Endogenous digitalis-like substance
HSS Hepatic Stimulatory Substance
I-SP Immunoreactive substance P
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • receptive substance
    ¼ö¿ë ¹°Áú
    ±ÙÀ° Á¶Á÷, ƯÈ÷ ½Å°æÀÇ ¿îµ¿ Á¾ÆÇ ±Ùó¿¡ ÀÖÀ¸¸ç ÈïºÐÀ» ÀüµµÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ´Â ¹°Áú.
  • slow-reating substance
    Áö¹ÝÀÀ¼º ¹°Áú
    ¾î¶² ÆòȰ±ÙÀÇ ´À¸®°í Áö¼Ó¼ºÀÎ ¼öÃàÀ» ÀÏÀ¸Å°´Â ¾Æ³ªÇʶô½Ã ¹ÝÀÀ ½Ã¿¡ ¹æÃâµÇ´Â ¹°Áú ±âÈ£ SRS-A.
  • substance defect
    ¹°Áú °áÇÌ
  • substance P fiber
    P ¹°Áú ¼¶À¯
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
  • transmitter substance
    Àü´Þ ¹°Áú
  • white substance
    ¹é»ö Áú
  • acquired disorder
    ÈÄõ¼º Àå¾Ö
    ¼±ÃµÀûÀÌ ¾Æ´Ï°í Ãâ»ý ÈÄ Á¤»óÀûÀÎ ¹ßÀ°¿¡ ÀÌ»óÀÌ »ý±â°Å³ª, º¯È­°¡ ¿À°Å³ª, Àå¾Ö°¡ ÀϾ °Í.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö, ÀûÀÀÀå¾Ö º´
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö, ÀûÀÀ¼º ¼ö¸éÀå¾Ö º´, ¼ö¸é Á¶Á¤ Àå¾Ö, ¼ö¸é Á¶Á¤ Àå¾Ö º´
  • affective disorder
    Á¤µ¿Àå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀû ÀÎ°Ý Àå¾Ö
  • anxiety disorder
    ºÒ¾È Àå¾Ö
    °­¹ÚÁõ, ¿Ü»ó ÈÄ ½ºÆ®·¹½ºÀå¾Ö, °øÆ÷Áõ, °øÈ²Àå¾Ö¸¦ Æ÷ÇÔÇÏ´Â ³ÐÀº ÀǹÌÀÇ ½É¸®Àû Áúº´À¸·Î¼­ ºÒ¾È¿¡ ´ëÇÑ ºñÇö½ÇÀûÀ̰í Áö¼ÓÀûÀÎ ´À³¦, ºÒÈ®½Ç¼º, ¹Ì·¡ÀÇ ¿ì·Á³ª À§Çè¿¡ ´ëÇÑ µÎ·Á¿òÀÌ Æ¯Â¡À̸ç, ±äÀå°¨À̳ª ºÒ¾ÈÀ» µ¿¹ÝÇÑ´Ù. À̰ÍÀº ÀûÀÀ ±â´ÉÀÌ Á¦ÇѵǸç, ȯÀÚ¸¦ ¾È½É½Ã۸é Áõ»óÀÌ ¿ÏÈ­µÈ´Ù.
  • articular disorder
    °üÀý Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
chromidial substance Endoplasmic reticulum in which ribosomal granules are applied to the cytoplasmic surface of the cisternae; involved in the synthesis and secretion of protein via membrane-bound vesicles to the extracellular space.
Synonym: chromidial substance, ergastoplasm, rough-surfaced endoplasmic reticulum.
(05 Mar 2000)
chromophil substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
compact substance The compact, noncancellous portion of bone that consists largely of concentric lamellar osteons and interstitial lamellae.
Synonym: substantia compacta, compact substance, substantia compacta ossium.
(05 Mar 2000)
white substance <anatomy> Brain tissue composed of myelin-coated nerve cell fibres. White matter carries information between the nerve cells in the brain and spinal cord.
The inner portion of the cerebrum is composed of white matter.
See: grey matter.
(13 Nov 1997)
mullerian inhibiting substance A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin.
Synonym: mullerian inhibiting factor.
(05 Mar 2000)
muscular substance of prostate The smooth muscle in the stroma of the prostate.
Synonym: substantia muscularis prostatae, musculus prostaticus.
(05 Mar 2000)
controlled substance A substance subject to the Controlled Substances Act (1970), which regulates the prescribing and dispensing, as well as the manufacturing, storage, sale, or distribution of substance's assigned to five schedules according to their 1) potential for or evidence of abuse, 2) potential for psychic or physiologic dependence, 3) contributing a public health risk, 4) harmful pharmacologic effect, or 5) role as a precursor of other controlled substance's.
(05 Mar 2000)
cortical substance The superficial thin layer of compact bone.
Synonym: substantia corticalis, cortical substance.
(05 Mar 2000)
posterior perforated substance The bottom of the interpeduncular fossa at the base of the midbrain, extending from the anterior border of the pons forward to the mamillary bodies, and containing numerous openings for the passage of perforating branches of the posterior cerebral arteries.
Synonym: substantia perforata posterior, locus perforatus posticus, Malacarne's space.
(05 Mar 2000)
pressor substance One of several products of intestinal putrefaction believed to cause functional hypertension when absorbed, any alkaline substance that raises blood pressure.
Synonym: pressor amine, pressor substance.
(05 Mar 2000)
proper substance See: substantia propria of cornea, substantia propria membranae tympani, substantia propria sclerae.
(05 Mar 2000)
schwann's white substance <anatomy> The substance of the medullary sheath.
Source: Websters Dictionary
(01 Mar 1998)
psychoses, substance-induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
(12 Dec 1998)
sensitizing substance Antibody that combines with and sensitises antigen leading to the activation of complement, which may result in cell lysis.
Synonym: CF antibody, sensitizing substance.
(05 Mar 2000)
h substance <haematology> A polysaccharide precursor molecule which is used to make the antigens on the surface of human blood cells that are classified in the ABO blood group system.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á